期刊文献+

SARS冠状病毒S蛋白噬菌体抗原库的构建及筛选 被引量:1

Construction and Screening of SARS-CoV S Protein-specific Phage Displayed Antigen Library
原文传递
导出
摘要 本研究旨在构建SARS冠状病毒S蛋白特异性噬菌体抗原库,并用于鉴定抗S蛋白单克隆抗体的抗原表位。首先采用PCR技术扩增出SARS冠状病毒S蛋白的全基因,以DNaseI将其随机酶切成50~500bp不同大小的DNA片段。然后将DNA片段平末端化并连接到经过改造的噬菌体表达载体pComb3XSS,经电转化大肠杆菌XL1-Blue和辅助噬菌体感染获得S蛋白的特异性噬菌体抗原库。利用两个抗S蛋白单克隆中和抗体(S-M1和S-M2)对S蛋白抗原库进行富集和筛选。结果表明,我们成功构建库容量为5.7×106的S蛋白噬菌体抗原库。通过对S-M1和S-M2的有效富集和筛选,分别得到14个和15个阳性克隆,序列分析初步揭示了抗体的抗原表位。因此,S蛋白噬菌体抗原库的构建为鉴定S蛋白的抗原表位提供了重要的技术平台,对研发SARS疫苗和诊断试剂具有重要的科学意义和应用价值。 The aim of this study is to construct a SARS-CoV S protein-specific phage displayed antigen li- brary for the epitope characterization of anti-S monoclonal antibodies (mAbs). First, the full-length gene of SARS-S protein was PCR amplified, purified and then digested with DNase I to obtain DNA fragments in the size range of 50-500 bp. The resulting fragments were blunt-end ligated to the modified phage dis- play vector pComb3XSS. The reactions were electrotransformed into XL1-Blue and infected with VCSM13 helper phage. The SARS-CoV S protein-specific phage displayed antigen library was biopanned and screened against two anti-S mAbs, S-M1 and S-M2. The results showed that we successfully constructed the phage displayed antigen library with a size of 5.7× 106. After three-rounds of biopanning, 14 positive phage clones for S-M1 and 15 for S-M2 were respectively identified. Sequence analyses revealed the possi- ble epitopes of two mAbs. Therefore, the S protein-specific phage displayed antigen library provides a cru- cial platform for the epitope characterization of anti-S antibodies and it is highly valuable for development of SARS vaccines and diagnostics.
出处 《病毒学报》 CAS CSCD 北大核心 2013年第3期280-286,共7页 Chinese Journal of Virology
基金 国家十二五艾滋病和病毒性肝炎等重大传染病防治专项(2012ZX10001-008) 国家杰出青年基金(81025009)
关键词 SARS冠状病毒 S蛋白 噬菌体抗原库 单克隆抗体 抗原表位 SARS coronavirus S protein Phage antigen library Monoclonal antibody Antigenic epitope
  • 相关文献

参考文献21

  • 1Drosten C,Günther S,Preiser W,et al.Identification ofa novel coronavirus in patients with severe acute respira-tory syndrome[J]. N Engl J Med,2003,348(20):1967-1976.
  • 2Ksiazek T G,Erdman D,Goldsmith C S,et al.A novelcoronavirus associated with severe acute respiratory syn-drome[J]. N Engl J Med,2003,348(20):1953-1966.
  • 3Marra M A,Jones S J,Astell C R,et al.The Genome se-quence of the SARS-associated coronavirus[J]. Science,2003,300(5624):1399-1404.
  • 4Rota P A,Oberste M S,Monroe S S,et al.Characteriza-tion of a novel coronavirus associated with severe acuterespiratory syndrome[J]. Science,2003,300(5624):1394-1399.
  • 5David R.New coronavirus[J]. Nat Rev Microbiol,2012,10(11):730-730.
  • 6Yang Z Y,Kong W P,Huang Y,et al.A DNA vaccineinduces SARS coronavirus neutralization and protectiveimmunity in mice[J]. Nature,2004,428(6982):561-564.
  • 7He Y,Li J,Heck S,et al.Antigenic and immunogeniccharacterization of recombinant baculovirus-expressedsevere acute respiratory syndrome coronavirus spike pro-tein:implication for vaccine design[J]. J Virol,2006,80(12):5757-5767.
  • 8Du L,He Y,Zhou Y,et al.The spike protein of SARS-CoV--a target for vaccine and therapeutic development[J]. Nat Rev Microbiol,2009,7(3):226-236.
  • 9Cortese R,Monaci P,Luzzago A,et al.Selection of bio-logically active peptides by phage display of random pep-tide libraries[J]. Curr Opin Biotech,1996,7:616-621.
  • 10Wang L F,Yu M.Epitope identification and discoveryusing phage display libraries:applications in vaccine de-velopment and diagnostics[J]. Curr Drug Targets,2004,5:1-15.

同被引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部